Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis - ZODIPSO Study

NCT05938361 is registered in ClinicalTrials.gov with Clin4all as lead sponsor.

NCT NCT05938361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05938361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis - ZODIPSO Study
Lead sponsor
Clin4all
Phase
Observational
Overall status
Completed
Start date
June 1, 2023
Completion date
October 6, 2025
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis genital, psoriasis nail, psoriasis of scalp, psoriasis palmaris, psoriasis plantaris